Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

ABSTRACT The novel coronavirus, SARS-coronavirus (CoV)-2 (SARS-CoV-2), has caused over 17 million infections in just a few months, with disease manifestations ranging from largely asymptomatic infection to critically severe disease. The remarkable spread and unpredictable disease outcomes continue t...

Full description

Bibliographic Details
Main Authors: Carolin Loos, Caroline Atyeo, Stephanie Fischinger, John Burke, Matthew D. Slein, Hendrik Streeck, Douglas Lauffenburger, Edward T. Ryan, Richelle C. Charles, Galit Alter
Format: Article
Language:English
Published: American Society for Microbiology 2020-10-01
Series:mSphere
Subjects:
Fc-receptor binding
SARS-CoV-2
antibody response
cross-reactivity
Online Access:https://journals.asm.org/doi/10.1128/mSphere.00622-20

Internet

https://journals.asm.org/doi/10.1128/mSphere.00622-20

Similar Items